美诺华 (603538)

1. Key Indicators

• Total Shares(W): 22061.83
• Circulating A-Shares(W): 21618.29
• Earnings Per Share(RMB): 0.4300
• Net Assets Per Share(RMB): 10.1859
• Operating Revenue(W RMB): 111679.36
• Total Profit(W RMB): 11817.84
• **Net Profit Attributable to Parent(W RMB) **: 9592.54
• Net Profit Growth Rate(%): 51.66
• Weighted Return on Equity(%): 4.2600
• Operating Cash Flow Per Share(RMB): 0.1450
• Undistributed Profit Per Share(RMB): 6.1551
• Capital Reserve Per Share(RMB): 3.0514

---

2. Main Business

The main business covers:

• Research, production, and sales of specialty active pharmaceutical ingredients (APIs) and pharmaceutical intermediates.

---

3. Company Basic Information

• Company Name: Ningbo Menovo Pharmaceutical Co., Ltd.
• Listing Date: 2017-04-07
• Industry: Pharmaceutical Manufacturing
• Address: Room 1406, No. 1, Lane 999, Yangfan Road, High-tech Zone, Ningbo City, Zhejiang Province
• Website: https://www.menovopharm.com
• Company Profile: The issuer was established as a joint stock limited company through the overall change of Menovo Pharmaceutical Co., Ltd. On January 10, 2012, Menovo Pharmaceutical Co., Ltd. held a shareholders' meeting and agreed to change the company into a joint stock limited company. According to the "Audit Report" (Xin Hui Shi Bao Zi [2012] No. 110020) issued by Lixin Certified Public Accountants, the net assets of the limited company as of December 31, 2011, were RMB 267,624,738.15. This amount was converted into 90 million shares at a ratio of approximately 1:0.3363, with a par value of RMB 1 per share, all of which are ordinary shares. The total share capital of the joint stock company was RMB 90 million, and the portion not included in the share capital, RMB 177,624,738.15, was recorded as the company's capital reserve. On January 12, 2012, Lixin Certified Public Accountants verified the receipt of the registered capital when the issuer was changed to a joint stock limited company and issued the "Capital Verification Report" (Xin Hui Shi Bao Zi [2012] No. 110079). On January 30, 2012, the joint stock company held its founding meeting, reviewed and adopted the "Company Articles of Association," and elected the first board of directors and board of supervisors. On February 14, 2012, the joint stock company was registered and established with the Ningbo Municipal Administration for Market Regulation in Zhejiang Province, with a registration number of 330215000002952 and a registered capital and share capital of RMB 90 million.

---

4. Top 10 Circulating Shareholders

Rank	Institution Name	Institution Type	Shares Held (W)	Percentage Held (%)
1	Ningbo Menovo Pharmaceutical Holding Group Co., Ltd.	Corporate Legal Person	4528.57	20.95
2	J. P. Morgan Securities PLC - Proprietary Funds	QFII	186.10	0.86
3	Xinhua Preferred Dividend Hybrid Securities Investment Fund - Class A	Fund	131.29	0.61
4	CITIC Securities Asset Management (Hong Kong) Limited - Client Funds	Asset Management Plan	130.84	0.61
5	UBS AG	QFII	92.63	0.43
6	Xinhua Strategy Select Stock Securities Investment Fund - Class A	Fund	84.97	0.39
7	Fuanda Pharmaceutical Innovation Mixed Securities Investment Fund	Fund	23.55	0.11
8	Fuanda Healthy Life Flexible Allocation Mixed Securities Investment Fund - Class A	Fund	9.97	0.05
9	Xinhua Industry Leading Theme Stock Securities Investment Fund	Fund	4.68	0.02
10	CITIC Securities Construction Investment Shuangxin Bond Securities Investment Fund - Class A	Fund	0.16	0.00

---

5. Concept Sectors

• Convertible Bonds
• CXO Concept
• Assisted Reproduction
• Hepatitis Concept
• Weight Loss Drugs
• Synthetic Biology
• Pet Economy
• Margin Trading & Securities Lending
• QFII Heavy Holdings

---

Remarks

• Data update date: 2025-09-30
• Data source: Public Market Information